Sastasundar Ventures
add_icon

Sastasundar Ventures

296.90
+4.90
(1.68%)
Market Cap
944.45 Cr
PE Ratio
-101.77
Volume
5,304.00
Day High - Low
300.15 - 290.65
52W High-Low
363.00 - 205.00
ann
There are new updates from the company21 hrs ago
Viewcross
right
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
944.45 Cr
EPS
-28.66
PE Ratio
-101.77
PB Ratio
1.35
Book Value
214.24
EBITDA
3.80
Dividend Yield
0.00 %
Return on Equity
-15.45
Debt to Equity
0.00
Forecast For
Actual

Company News

View All News
Caret
neutral
Sastasundar Ventures Limited has scheduled a board meeting for February 6, 2026, to consider and approve Q3FY26 unaudited financial results for quarter ended December 31, 2025.
neutral
Sastasundar Ventures Limited announces postal ballot seeking shareholder approval for name change to Health X Platform Limited and amendments to main object clause, with e-voting from January 15 to February 13, 2026.
positive
Sastasundar Ventures Limited board approves name change to Health X Platform Limited and MOA amendments to expand into healthcare and digital platform services, subject to shareholder approval.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,409.50
#1 23,616.32
43.29
#1 2,554.80
11.28
#1 492
16.36
43.84
958.70
9,848.24
63.41
699.70
23.06
144
2.85
33.25
1,873.00
9,706.26
58.78
1,346.30
10.64
146
13.28
37.22
420.00
6,684.79
49.78
702.20
20.80
91
47.37
39.00
527.70
5,294.98
76.67
769.90
33.97
67
-
59.36
712.10
2,309.96
27.01
742.70
16.70
78
22.45
41.27
1,692.00
1,452.21
28.70
111.60
28.72
48
0.67
60.18
265.95
1,385.09
43.29
255.90
15.11
31
-13.73
40.80
529.50
1,034.80
#1 22.60
147.80
#1 134.60
19
#1 760.87
44.49
296.90
#10 944.45
#10 -101.77
#3 1,170.80
#10 -18.47
#10 -134
#2 90.05
38.85
Growth Rate
Revenue Growth
-18.47 %
Net Income Growth
-2,362.71 %
Cash Flow Change
-148.27 %
ROE
-2,718.64 %
ROCE
750.91 %
EBITDA Margin (Avg.)
-92.79 %

Quarterly Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Revenue
17
19
21
32
25
30
38
32
37
39
37
50
48
51
54
56
61
75
93
105
117
137
142
138
134
174
163
1,314
161
197
260
285
322
348
368
395
325
299
296
270
308
324
307
Expenses
22
23
28
38
35
36
41
38
41
44
39
45
52
56
60
65
75
89
105
116
132
137
144
141
141
178
169
156
194
222
269
291
324
327
355
371
317
273
468
307
311
292
324
EBITDA
-6
-4
-7
-5
-10
-6
-3
-5
-4
-5
-2
5
-4
-5
-7
-8
-14
-14
-12
-11
-15
0
-2
-2
-7
-4
-6
1,158
-33
-25
-8
-6
-3
21
13
24
8
26
-172
-38
-3
31
-17
Operating Profit %
-43 %
-27 %
-37 %
-18 %
-43 %
-23 %
-9 %
-18 %
-19 %
-14 %
-8 %
-3 %
-11 %
-13 %
-13 %
-19 %
-24 %
-19 %
-13 %
-12 %
-14 %
-0 %
-2 %
-2 %
-6 %
-3 %
-6 %
-9 %
-24 %
-16 %
-6 %
-4 %
-4 %
3 %
1 %
1 %
-3 %
-1 %
-71 %
-9 %
-9 %
2 %
-8 %
Depreciation
2
2
2
2
2
2
2
2
2
2
1
1
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
2
2
3
2
2
2
3
2
2
1
1
1
1
Interest
0
0
0
1
1
0
1
1
1
1
0
0
0
0
1
1
1
0
1
0
-0
0
0
0
0
0
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Profit Before Tax
-8
-6
-9
-8
-13
-8
-5
-8
-7
-7
-4
3
-5
-7
-9
-11
-16
-16
-14
-12
-16
-1
-3
-4
-9
-6
-8
1,157
-34
-26
-11
-9
-6
19
11
21
5
25
-174
-39
-5
30
-19
Tax
-1
0
0
0
-1
0
0
0
0
0
0
2
0
0
0
0
0
-5
0
0
-0
0
0
0
0
1
1
133
-8
-1
-8
18
42
19
23
24
-17
-16
-19
-1
-22
4
-3
Net Profit
-6
-6
-9
-8
-12
-9
-5
-8
-7
-7
-4
2
-5
-7
-9
-11
-16
-10
-14
-12
-15
-1
-4
-4
-9
-6
-9
1,024
-26
-25
-3
-26
-48
-0
-12
-3
22
41
-155
-38
18
27
-15
EPS in ₹
-1.96
-1.91
-2.83
-2.43
-3.80
-2.69
-1.67
-2.43
-2.24
-2.20
-0.97
-0.68
-1.33
-1.92
-2.47
-3.02
-4.39
-2.62
-3.82
-2.69
-3.06
-0.04
-0.70
-0.63
-1.90
-1.14
-1.43
232.31
-6.07
-6.24
-0.39
-6.00
-10.75
0.41
-2.55
-0.23
5.17
9.79
-34.40
-8.47
4.30
7.52
-3.99

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
281
256
251
236
231
316
293
1,278
1,206
1,150
974
Fixed Assets
138
126
125
117
116
114
110
93
107
110
102
Current Assets
88
90
108
95
66
137
131
508
575
354
267
Capital Work in Progress
3
0
0
1
1
0
0
0
1
0
10
Investments
4
1
8
28
36
56
43
666
513
676
575
Other Assets
137
129
119
89
77
146
139
518
585
363
287
Total Liabilities
281
256
251
236
231
316
293
1,278
1,206
1,150
974
Current Liabilities
22
31
49
27
22
66
60
68
110
79
105
Non Current Liabilities
4
7
7
5
8
3
3
116
102
72
5
Total Equity
255
218
195
203
200
246
229
1,094
994
1,000
865
Reserve & Surplus
223
186
158
144
106
173
163
790
717
726
638
Share Capital
32
32
32
32
32
32
32
32
32
32
32

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
-1
-0
7
-2
-6
11
-5
1
19
-0
-19
Investing Activities
7
-1
4
15
-2
-22
21
220
133
-34
-1
Operating Activities
-12
-12
-2
-49
-30
-69
-31
-207
-112
36
-17
Financing Activities
4
13
5
33
26
103
4
-11
-2
-2
-0

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Promoter
74.43 %
74.43 %
74.43 %
73.72 %
73.72 %
73.92 %
73.92 %
73.92 %
73.92 %
73.92 %
73.92 %
73.92 %
73.92 %
73.92 %
73.92 %
73.94 %
74.11 %
74.24 %
74.24 %
74.69 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.32 %
0.49 %
0.56 %
0.61 %
0.99 %
1.71 %
1.60 %
1.88 %
2.04 %
2.25 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.09 %
0.09 %
0.09 %
0.17 %
0.17 %
0.86 %
0.96 %
1.35 %
1.98 %
1.85 %
2.06 %
2.09 %
2.07 %
2.07 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
11.41 %
13.05 %
13.03 %
13.80 %
14.49 %
14.70 %
15.01 %
15.24 %
15.09 %
15.17 %
15.64 %
16.52 %
16.06 %
15.05 %
14.47 %
14.09 %
13.70 %
13.35 %
12.84 %
12.72 %
Others
14.16 %
12.52 %
12.55 %
12.48 %
11.79 %
11.38 %
10.98 %
10.76 %
10.90 %
10.74 %
9.95 %
8.20 %
8.51 %
9.07 %
8.63 %
8.41 %
8.52 %
8.44 %
8.81 %
8.27 %
No of Share Holders
11,797
13,034
13,090
14,276
15,174
15,247
15,554
15,166
15,088
14,752
14,633
14,053
14,544
14,493
15,360
14,093
13,693
13,452
13,012
12,287

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
27 Sept 2016 CHANGE OF NAME Change Of Name
NA
27 Sept 2016 0.00 0.00
30 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Sept 2024 307.85 306.85
14 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Nov 2024 335.25 318.20
14 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Feb 2025 282.35 275.90
30 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
30 May 2025 270.00 265.95
12 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Aug 2025 285.15 293.25
26 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
26 Sept 2025 271.55 307.40
13 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Nov 2025 298.55 289.85

Announcements

Board Meeting Intimation for Prior Intimation For Board Meeting To Be Held On 6Th February 202621 hrs ago
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 14, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 14, 2026
Shareholder Meeting / Postal Ballot-Notice of Postal BallotJan 13, 2026
Board Meeting Outcome for Outcome Of Board Meeting Held On 7Th January 2026 - Intimation Under Reg 30 Of SEBI (LODR) Reg 2015 Jan 07, 2026
Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Reg 2015Dec 31, 2025
Closure of Trading WindowDec 26, 2025
Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Reg 2015Dec 17, 2025
Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Reg 2015Dec 11, 2025
Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Reg 2015Dec 08, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationDec 04, 2025
Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Reg 2015Dec 02, 2025
Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Reg 2015Nov 29, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 24, 2025
Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Reg 2015Nov 22, 2025
Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Reg 2015Nov 20, 2025
Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Reg 2015Nov 19, 2025
Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Regulations 2015Nov 18, 2025
Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Regulations 2015Nov 18, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 17, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 15, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationNov 13, 2025
Results - Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended 30Th September 2025Nov 13, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On 13Th November 2025Nov 13, 2025
Disclosure Under Reg 30 Of SEBI (LODR) Reg 2015 - Update On The Buy-Back Proposal By Sastasundar Healthbuddy Limited Unlisted Material Subsidiary Of The CompanyNov 11, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 10, 2025
Board Meeting Intimation for Unaudited Financial Results For The Quarter And Half Year Ended 30Th September 2025Nov 03, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 13, 2025
Disclosure Under Reg 30 Of SEBI (LODR) Reg 2015 - Update On The Buy-Back Proposal By Sastasundar Healthbuddy Limited Unlisted Material Subsidiary Of The CompanySep 30, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 27, 2025
Disclosure Of Voting Results In Terms Of Regulation 44 Of SEBI (LODR) Reg 2015 And Revised ScrutinizerS Report Of 36Th AGMSep 27, 2025
Closure of Trading WindowSep 26, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 26, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 26, 2025
Closure of Trading WindowSep 19, 2025
Disclosure Under Reg 30 Of SEBI (LODR) Reg 2015 - Buy-Back Proposal By Sastasundar Healthbuddy Limited Material Subsidiary Of The CompanySep 19, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 03, 2025
Disclosure Under Reg 30 Of SEBI (LODR) - Dispatch Of Letter To Shareholders Whose E-Mail Addresses Are Not Registered With The Company Or RTA Or Depository ParticipantsSep 02, 2025
Business Responsibility and Sustainability Reporting (BRSR)Sep 02, 2025
Reg. 34 (1) Annual Report.Sep 02, 2025
Notice Of The 36Th Annual General Meeting Of The CompanySep 02, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 30, 2025
Intimation Regarding Annual General Meeting And Book ClosureAug 29, 2025
Intimation Regarding Annual General Meeting And Book ClosureAug 29, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportAug 19, 2025
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotAug 19, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationAug 16, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 13, 2025
Amendment To The Code Of Practices And Procedures For Fair Disclosure Of Unpublished Price Sensitive InformationAug 12, 2025
Results - Unaudited Financial Results Standalone And Consolidated For The Quarter Ended 30Th June 2025Aug 12, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Bandhan BSE Healthcare Index Fund Direct-Growth
0.02%
0
0.00%
0.00%

Technical Indicators

RSI(14)
Neutral
38.85
ATR(14)
Volatile
12.99
STOCH(9,6)
Oversold
8.03
STOCH RSI(14)
Oversold
12.40
MACD(12,26)
Bearish
-2.83
ADX(14)
Weak Trend
21.07
UO(9)
Bearish
34.88
ROC(12)
Downtrend And Accelerating
-8.99
WillR(14)
Oversold
-97.19